The COVID-19 pandemic forced a number of changes, many of which will remain in place long after it subsides. One important but under-recognized shift could be in the field of clinical diagnostics.

This study shows that a beneficial yeast, Saccharomyces cerevisiae, reduces fungal infection and inflammation in vulvovaginal candidiasis by weakening pathogen virulence and improving immune responses ...